Gebelik Dönemi ve Kök Hücre Mucizesi

Son yıllarda kök hücre çalışmalarıyla ilgili gelişmeler, gebelik döneminde görülen hastalıklarda kök hücre tedavisinin uygulanması konusunda umut verici olmuştur. Gebelik döneminde görülen bazı spesifik hastalıklarda kök hücre tedavisine yönelik deneysel çalışmalar yapılmıştır. Deneysel çalışmalar yasal ve etik prosedürler nedeniyle henüz gebeler üzerinde gerçekleştirilmemiştir. Ratlar üzerinde yapılan çalışmalar, gebelik döneminde görülen sistemik lupus eritamatozus ve myokardiyal sorunların tedavisinde umut verici olmuştur. Gebelik döneminde yaşanan sağlık sorunlarda kök hücre tedavisi umut verici olsa da birçok etik tartışmayı beraberinde getirmektedir. Bu derleme; gebelik döneminde kök hücre, gebelik döneminde görülen sağlık sorunlarında kök hücre tedavisi ve kök hücre tedavisinden sonra gebelik konularının literatür doğrultusunda incelenmesi amacıyla yapılmıştır.

Pregnancy and The Miracle of Stem Cells

Developments regarding stem cell studies in recent years have been promising in implementation of stem cell therapy on diseases during pregnancy. Experimental studies have been conducted on stem cell therapy of some specific diseases which is seen during pregnancy. Yet, due to legal and ethical procedures experimental studies have been not performed on pregnant women. Studies on rats have been promising in the treatment of systemic lupus erythematosus and myocardial problem during pregnancy. Stem cell therapy gives rise to many ethical debate, even if it is promising on treatment of health problems during pregnancy. This review was conducted to investigate accordance with the literature about stem cell during pregnancy, stem cell therapy in health problems during pregnancy and pregnancy after stem cell therapy.

PDF

___

Arat, M. (2004). Engrafman, tanımı ve belirlenmesi ve kimerizm tayini. Kan ve Kemik İliği Transplantasyonu Kurs Kitabı. Roche Sanayi A.Ş., İzmir, 107-113.
Bordet, S., Nguyen, T. M., Knoppers, B. M., Isasi, R. (2010). Use of umbilical cord blood for stem cell research. Obstet Gynaecol Can., 32(1): 58-61.
Buchsel, P. C., Leum, E., Randolph, S. R. (1997). Nursing care of the blood cell transplant recipient. Semin Oncol Nurs., 13(3): 172-183.
Chatterjee, R., Mills, W., Katz, M., McGarrigle, H. H., Goldstone, A. H. (1994). Prospective study of pituitary-gonadal function to evaluate short-tenn elf ects of ablative chemotherapy or total body irradiation with autologous or allogenic marrow transplantation in post-menarcheal female patients. Bone Marrow Transplant, 13(5): 511-517.
Chen, J. ve ark. (2001). Intravenous administration of human umbilical cord blood reduces behavioral defıcits after stroke in rats. Stroke, 32(11): 2682-2688.
Cohen, A. ve ark. (1991). Pubertal development and fertility in children after bone marrow transplantion. Bone Marrow Transplant, 8(1): 16-20.
Fujiki, Y., Johnson, K. L., Peter, l., Tighiouart, H., Bianchi, D. W. (2009). Fetal cells in the pregnant mouse are diverse and express variety of progenitor and differentiated cell markers. Biology of Reproduction, 81(1): 26-32. 188
Halime Esra PARTOVİ MERAN, Ümran OSKAY Gallego, M. J. ve ark. (2010). The pregnancy hormones human chorionic gonadotropin and progesterone induce human embryonic stem cell proliferation and differentiation into neuroectodennal rosettes. Stem Cell Res Ther, 1(4): 1-13.
Hemşirelik Yönetmeliğinde Değişiklik Yapılmasına Dair Yönetmelik (2011). http://www.turkhemsirelerdernegiorg.tr/menu/yo-- netme1ikler/hemsirelikyonetmeligi.aspx (18 .0 .20 13).
Hodges, R. J., Bardien, N., Wallace, E. (2012). Acceptability of stem cell therapy by pregnant women. Birth, 39(2): 91-97
ICMR-DBT Guidelines for Stem Cell Research. (2012). Indian Council of Medical Research Department of Health Research Department of Biotechnology, http://icmr.nic.in/stem_cell_guidelines.pdf(18.01.2013).
Kapucu, S. S., Karaca, Y. (2008). Kök hücre naklinde hasta degerlendirmesi ve bakım. C. Ü. Hemşirelik Dergisi, 12(3): 52-59.
Kara, R. J. ve ark. (2012). Fetal cells traffic to injured maternal myocardium and undergo cardiac differentiation. Circulation research, 110(1): 82-93.
Karaöz, E. (2004). Göbek kordonu kök hücreleri embriyonik kök hücrelere alternatif olabilir mi? TÜBİTAK Bilim ve Teknik Dergisi, Mart 2004: 62-64.
Karaöz, E., Oval, E. (2007). Kök hücreler ve kök hücre bankacılıgı. EGİAD Yarzn Der., 17(1): 134-138.
Kemik İliği Nakli Hemşireliği Derneği (2012). http://www.kithemsireleri.com (18.01.2013).
Karaöz, E., Oval, E. (2007). Kemoterapi ve radyoterapi toksisitesi, etkileşimleri ve ilaç monitarizasyonu. Kan ve Kemik İliği Transplantasyonu Kurs Kitabı. Roche Sanayi A.Ş., İzmir,79-83.
Kolios, G., Moodley, Y. (2013). Introduction to stem cells and regenerative medicine. Respiration, 85(1): 3-10.
Laughlin, M. J., Eapen, M., Rubinstein, P. (2004). Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults With leukemia. New England Journal ofMedicine, 351(22): 2265-2275.
Lui, K. O., Waldmann, H., Fairchild, P. J. (2009). Embryonic stem cells: Overcoming the immunological barriers to cell replacement therapy. Curr Stem Cell Res Ther, 4(1): 70-80.
McGuckin, C. P. ve ark. (2005). Production of stem cells with embryonic characteristics from human umbilical cord blood. Cell Prolif., 38(4): 245-255.
Meng, J., Wang, J., Liang, W., Qin, S., Wu, C. (2011). Long-term remission after successful pregnancy in autologous peripheral blood stem cell transplanted system lupus erythematosus patients. Rheumatol Int., 31(5): 691-694.
Moise, K. J. (2005). Umbilical cord stem cells. Obstetrics Gynecology, 106(6): 1393-1407.
Osada, H. ve ark. (2001). Detection of fetal hpcs in maternal circulation after delivery. Transfusion, 41(4): 499-503.
Patient guide for stem cell mobilisation (2012). Myeloma Euronet AISBL, www.myeloma--euronet.org (18.01.2013).
Portmann-Lanz, C. B. ve ark. (2010). Neurogenic characteristics of placental stem cells in preeclampsia. Am Obstet Gynecol, 203(4): 399.el-399.e7.
Salooja, N. ve ark. (2001). Pregnancy outcomes after peripheral blood or bone marrow transplantation: retrospective survey. The Lancet, 358(9278): 271-276.
Sanders, J. E. ve ark. (1996). Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood, 87(7): 3045-3052.
Schechter, T., Finkelstein, Y., Doyle, ., Koren, G. (2005). Pregnancy after stem cell transplantation. Can Fam Physician, 51(6): 817-818.
Tan, X. W. ve ark. (2005). Fetal microchimerism in the maternal mouse brain: novel population of fetal progenito or stem cells able to cross the blood-brain barrier? Stem Cells, 23(10): 1443- 1452.
Türk Hematoloji Derneği (2010). Kök hücre nakli, http://www.thd. org.tr/thd_halk/?sayfa=Kok_Hucre_Nakli (1 .03 .20 4).
Wahid, F. S. A. ve ark. (2012). Effects of preeclampsia on the yield of hematopoietic stem cells obtained from umbilical cord blood at delivery. Obstet Gynaecol, 38(3): 490-497.
Wang, Y. ve ark. (2004). Fetal cells in mother rats contribute to the remodeling of liver and kidney after injury. Biochem Biophys Res Commun., 325(3): 961-967.
Yıldırım, G., Hotun- Şahin, N. (2007). Kök hücre nakli ve hemşirelik yaklaşımı. İ. F. N. Hem. Derg., 15(60): 188-194.
Young, B. K. (2006). Emerging stem cell therapies: The role of cord blood banks. Supplement to OBG Management: 3-16, http:// www.obgmanagement.com. (18.01.2013).